OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Help
Advanced
Search
23
Results
Show all
Save search
Copy query
Show results for
Unknown
(23)
Publication Date
Release Date
2025
(6)
2024
(6)
2022
(5)
2021
(3)
2020
(1)
2016
(1)
2014
(1)
Previous
page
1 / 3
You're on page
1
page
2
page
3
Next
page
Sort
by:
Relevance
Page size
10
Inflammatory biomarkers as independent prognosticators of 28-day mortality for COVID-19 patients admitted to general medicine or ICU wards: a retrospective cohort study.
Not available
S-EPMC7836340
|
biostudies-literature
Cite
COVID-19 in children with neuromuscular disorders.
Not available
S-EPMC7775833
|
biostudies-literature
Cite
Diversity, structure and convergent evolution of the global sponge microbiome.
Not available
S-EPMC4912640
|
biostudies-literature
Cite
Micra leadless pacemaker revisions: incidence, characteristics, and outcomes from a multicentre French cohort.
Not available
S-EPMC12669896
|
biostudies-literature
Cite
Plasma AR Alterations and Timing of Intensified Hormone Treatment for Prostate Cancer: the STAMPEDE Phase 3 Randomized Clinical Trial.
Not available
S-EPMC11869088
|
biostudies-literature
Cite
Global collision-risk hotspots of marine traffic and the world's largest fish, the whale shark.
Not available
S-EPMC9171791
|
biostudies-literature
Cite
Comprehensive vs. standard remote monitoring of cardiac resynchronization devices in heart failure patients: results of the ECOST-CRT study.
Not available
S-EPMC11472153
|
biostudies-literature
Cite
Effect of an individualized versus standard blood pressure management during mechanical thrombectomy for anterior ischemic stroke: the DETERMINE randomized controlled trial.
Not available
S-EPMC9317065
|
biostudies-literature
Cite
Durvalumab Plus Carboplatin/Paclitaxel Followed by Maintenance Durvalumab With or Without Olaparib as First-Line Treatment for Advanced Endometrial Cancer: The Phase III DUO-E Trial.
Not available
S-EPMC10824389
|
biostudies-literature
Cite
Factors associated with adverse haemodynamic events during the STARRT-AKI trial: a post-hoc secondary analysis.
Not available
S-EPMC12751851
|
biostudies-literature
Cite
Previous
page
1 / 3
You're on page
1
page
2
page
3
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets